Home › Funds › Mudita Advisors LLP › MXCT
Mudita Advisors LLP position in MXCT
MAXCYTE INC · Health Care
Mudita Advisors LLP reported holding 3,370,689 shares of MXCT (MAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.86% of its reported portfolio and ranking #19 among its reported holdings. Mudita Advisors LLP has disclosed MXCT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Mudita Advisors LLP's MXCT position evolved
Mudita Advisors LLP first disclosed a stake in MXCT in Q3 2023 at 1,390,858 shares (US$4.3M). The position peaked in Q4 2024 at 3,223,407 shares, worth US$13.4M. Across 12 filings, Mudita Advisors LLP increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,370,689 shares valued at US$4.1M. Notable position changes include a 35% increase in Q4 2023 (shares fell 11% over the following quarter), a 31% increase in Q2 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.39M | $4.34M | New |
| Q4 2023 | 1.88M | $8.84M | Add |
| Q1 2024 | 2.28M | $9.53M | Add |
| Q2 2024 | 2.99M | $11.71M | Add |
| Q3 2024 | 3.15M | $12.27M | Add |
| Q4 2024 | 3.22M | $13.41M | Add |
| Q1 2025 | 3.33M | $9.09M | Add |
| Q2 2025 | 3.37M | $7.35M | Add |
| Q3 2025 | 3.37M | $5.33M | Hold |
| Q4 2025 | 3.37M | $5.22M | Hold |
| Q1 2026 | 3.37M | $2.37M | Hold |
| Q2 2026 | 3.37M | $4.15M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MXCT and 13F data
MXCT (MAXCYTE INC) is a Health Care company. 24 other funds we track also report a position in MXCT — the largest reported positions include Capricorn Fund Managers Ltd (US$10.1M), Vitruvian Partners LLP (US$6.2M), CADIAN CAPITAL MANAGEMENT, LP (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MXCT
- Capricorn Fund Managers Ltd 8.20M sh · $10.09M · Q2 2026
- Vitruvian Partners LLP 5.04M sh · $6.20M · Q2 2026
- CADIAN CAPITAL MANAGEMENT, LP 2.20M sh · $2.71M · Q2 2026
- Peapod Lane Capital LLC 1.98M sh · $2.22M · Q3 2026
- Brooklands Fund Management Ltd 1.56M sh · $1.75M · Q3 2026
- NANO CAP NEW MILLENNIUM GROWTH FUND L P 1.20M sh · $1.48M · Q2 2026
More on Mudita Advisors LLP
FAQ
How long has Mudita Advisors LLP held MXCT?
Mudita Advisors LLP has disclosed MXCT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Mudita Advisors LLP's current position in MXCT?
As of Q2 2026, Mudita Advisors LLP holds 3.37M shares of MXCT (MAXCYTE INC), valued at $4.15M, representing 0.86% of its reported portfolio and ranking #19.
Has Mudita Advisors LLP been buying or selling MXCT?
In the latest 13F filing (Q2 2026), Mudita Advisors LLP held unchanged its position in MXCT. The position peaked in Q4 2024 at 3.22M shares.
Which other funds hold MXCT?
Other major institutional holders of MXCT include Capricorn Fund Managers Ltd, Vitruvian Partners LLP, CADIAN CAPITAL MANAGEMENT, LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.